ℹ️ Compiled from public regulatory records · Last regulator revision: March 13, 2026🚩 Report this page
Sotrovimab
Antiviral Monoclonal Antibodies
Sold as XEVUDY
GB MHRA
- Drug class
- Antiviral Monoclonal Antibodies
- Availability
- See label
- Markets covered
- 1
- Products on record
- 1
Overview
Sotrovimab is an active pharmaceutical ingredient in the Antiviral Monoclonal Antibodies group (J06BD). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 1 | March 13, 2026 |
GBUnited Kingdom· MHRA
1 product
Sources & citations
- [1]MHRA (UK) · PLGB194940301 · revised March 13, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.